Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. | ||
Founding Date | Founding Date 1916 | Founding Date 2010 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Parkville, AU HQ King Of Prussia, US | Locations Heze, CN HQ |
Employees | Employees 32,6982% increase | Employees 1,200 |
Valuation ($) | Valuation ($) 95.1 b | Valuation ($) 642.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $14.7b (FY, 2024) | Revenue (est.) ¥1.2b (FY, 2023) |
Cost of goods | Cost of goods $6.2b (FY, 2024) | Cost of goods ¥994.2m (FY, 2023) |
Gross profit | Gross profit $8.6b (FY, 2024) | Gross profit ¥271.8m (FY, 2023) |
Net income | Net income $2.7b (FY, 2024) | Net income ¥48.5m (FY, 2023) |